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薬物の徐放性機能を有する口腔内速崩壊錠の研究
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Fast-disintegrating (FD) tablets containing nicorandil-loaded dry emulsions were prepared and their controlled-
release properties were examined and compared with the plain FD tablets (FD tablets without dry emulsions) and com-
mercial tablets. The dry emulsions were prepared with myristyl alcohol and stearyl alcohol and their property was modi-
ˆed by mixing the ratio of the two alcohols. Disintegration time of the prepared FD tablets was su‹ciently fast ( i.e., 12
to 23 s). In vitro release of nicorandil from the FD tablets containing the dry emulsions was sustained over 6 h, while
that from plain FD and commercial tablets was complate within 5 min. In vivo absorption of nicorandil from the tablets
was evaluated by oral administration in beagle dogs. FD tablets containing dry emulsions showed a similar AUC, lower
Cmax, and delayed Tmax compared to the plain FD and commercial tablets. These results suggest that the dry emulsion-
loaded FD tablets can be utilized to improve the sustained-release property of active drugs.
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比が 2：3 のもので 8.45％，同比が 3：2では 6.80
％であった．また，用いたドライエマルションの粒
子径はミリスチルアルコールとステアリルアルコー
ル比が 2：3では 500―1000 mm，同比が 3：2では
300―500 mmである．
さらに，ドライエマルション封入速崩壊錠につい











































一夜絶食したビーグル犬 6頭を 3頭ずつ 2群に分
け，1群にニコランジル含有速崩壊錠 3錠あるいは
ニコランジル含有ドライエマルションの速崩壊錠 5
錠を 1回経口投与し，もう 1群にはシグマート錠 3
錠を 1回経口投与した（それぞれ，ニコランジルの
投与量は 15 又は 25 mg である）．投与後，5, 10,
15, 20, 30, 45, 60, 120, 240, 360, 480 minに前腕静脈








え，その 30 mlを HPLCに注入した．










カラムは Unisil Pack 5C18 逆相分離カラム（250




結 果 及 び 考 察
1. 口腔内速崩壊錠の調製と崩壊時間，硬度の検




スカルメロースナトリウム）の添加割合（0, 1, 2, 4,































vitro崩壊性，放出性と in vivo吸収性 1錠あた





Fig. 1. Disintegration Time and Hardness of Various Fast Disintegration Tablets
Each column and point represent the mean ± S.E. of four measurements. Hatched column: disintegrating time, closed circle: hardness.
Table 1. Disintegration Time and Hardness of Fast Disintegrating and Commercial Tablets
Preparation Disintegration time (s) Hardness (kg)
Fast disintegration tablet
without nicorandil (6 mm) 12.00±2.42 6.40±0.06
without nicorandil (10 mm) 23.00±1.00 6.43±0.09
with nicorandil (10 mm) 23.00±1.15 6.93±0.22
Commercial tablet 72.67±4.63 5.00±0.50





Table 1 に各錠剤の in vitro での崩壊時間及び硬
度を示す．直径 6 mmの速崩壊錠（ニコランジルな
















Fig. 2. Nicorandil Release from Dry Emulsion Loaded Fast
Disintegration Tablets
Each data point represents the mean ± S.E. of three measurements.
Symbols: ● commercial tablet, ○ plain fast disintegration tablet, ▲ dry
emulsion loaded fast disintegration tablet (myristyl alcohol : stearyl alcohol
＝2：3),△ dry emulsion loaded fast disintegration tablet (myristyl alcohol :
stearyl alcohol＝3：2).
Fig. 3. Plasma Concentration of Nicorandil after Oral Ad-
ministration of Fast Disintegration Tablets
Each data point represents the mean ± S.E. of 6 dogs. Symbols: ●
commercial tablet,○ plain fast disintegration tablet,△ dry emulsion loaded
fast disintegration tablet (myristyl alcohol : stearyl alcohol＝3：2). Dose of
nicorandil was 15 mg for commercial tablets and plain fast disintegration



















ルアルコール比が 2：3では 500―1000 mm，同比が































Table 2. Bioavailability of Fast Disintegration Tablets of Nicorandil
Preparation Cmax(ng/ml) Tmax(min) AUC (mg ･ h/ml)
Commercial tablet 1223.5±189.9 11.25±2.50 1.329±0.134
Plain fast disintegration tablet 939.5±128 28.75±8.29 1.383±0.076
Dry emulsion loaded fast disintegration tablet 642.9±38.1 60.00±0.00 1.902±0.128
Dose of nicorandil was 15 mg for commercial tablets and plain fast disintegration tablets, and 25 mg for dry emulsion loaded fast disintegration tablets. Each
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